Get started
Author

Philippe Gourlet

Observed names: Gourlet, Philippe, P Gourlet, P. GOURLET, P. Gourlet, PHILIPPE GOURLET, Philippe GOURLET
OpenAlex ID: A5046473005
Structural requirements for the occupancy of pituitary adenylate‐cyclase‐activating‐peptide (PACAP) receptors and adenylate cyclase activation in human neuroblastoma NB‐OK‐1 cell membranes
1992 · Patrick ROBBERECHT, Philippe GOURLET, et al. · European Journal of Biochemistry · 216
PDF
Development of High Affinity Selective VIP1 Receptor Agonists
1997 · Philippe Gourlet, Andre Vandermeers, et al. · Peptides · 200
In Vitro Properties of a High Affinity Selective Antagonist of the VIP1 Receptor
1997 · Philippe Gourlet, Philippe de Neef, et al. · Peptides · 183
The Long-Acting Vasoactive Intestinal Polypeptide Agonist RO 25-1553 Is Highly Selective of the VIP 2 Receptor Subclass
1997 · Philippe Gourlet, Pascale Vertongen, et al. · Peptides · 150
Presence of highly selective receptors for PACAP (pituitary adenylate cyclase activating peptide) in membranes from the rat pancreatic acinar cell line AR 4‐2J
1990 · Louis Buscail, Philippe Gourlet, et al. · FEBS Letters · 125
PDF
The novel VIP-like hypothalamic polypeptide PACAP interacts with high affinity receptors in the human neuroblastoma cell line NB-OK
1990 · Annick Cauvin, Louis Buscail, et al. · Peptides · 123
Properties and distribution of receptors for pituitary adenylate cyclase activating peptide (PACAP) in rat brain and spinal cord
1991 · Annick Cauvin, Patrick Robberecht, et al. · Regulatory Peptides · 93
Autoradiographic Visualization of the Receptor Subclasses for Vasoactive Intestinal Polypeptide (VIP) in Rat Brain
1997 · Pascale Vertongen, Serge N Schiffmann, et al. · Peptides · 91
Development of selective agonists and antagonists for the human vasoactive intestinal polypeptide VPAC2 receptor
2000 · D. Moreno, P. Gourlet, et al. · Peptides · 79
The C-Terminus Ends of Secretin and VIP Interact With the N-Terminal Domains of Their Receptors
1996 · Philippe Gourlet, Jean-Pierre Vilardaga, et al. · Peptides · 77
Fragments of pituitary adenylate cyclase activating polypeptide discriminate between type I and II recombinant receptors
1995 · Philippe Gourlet, André Vandermeers, et al. · European Journal of Pharmacology · 76
The two forms of the pituitary adenylate cyclase activating polypeptide (PACAP (1–27) and PACAP (1–38)) interact with distinct receptors on rat pancreatic AR 4‐2J cell membranes
1991 · Patrick Robberecht, Marie-Claire Woussen-Colle, et al. · FEBS Letters · 64
PDF
A new type of functional VIP receptor has an affinity for helodermin in human SUP‐T1 lymphoblasts
1988 · Patrick Robberecht, Magali Waelbroeck, et al. · FEBS Letters · 59
Structural requirements for the binding of the pituitary adenylate‐cyclase‐activating peptide to receptors and adenylate‐cyclase activation in pancreatic and neuronal membranes
1991 · Philippe GOURLET, Marie‐Claire WOUSSEN‐COLLE, et al. · European Journal of Biochemistry · 58
PDF
PACAP and VIP receptors in rat liver membranes
1991 · P. Robberecht, P. Gourlet, et al. · American Journal of Physiology-Gastrointestinal and Liver Physiology · 58
Chemical, immunological and biological properties of peptides like vasoactive‐intestinal‐peptide and peptide‐histidine‐isoleucinamide extracted from the venom of two lizards (Heloderma horridum and Heloderma suspectum)
1987 · Andé VANDERMEEERS, Philippe GOURLET, et al. · European Journal of Biochemistry · 57
Receptor occupancy and adenylate cyclase activation in AR 4-2J rat pancreatic acinar cell membranes by analogs of pituitary adenylate cyclase-activating peptides amino-terminally shortened or modified at position 1, 2, 3, 20, or 21.
1992 · P Robberecht, P Gourlet, et al. · Molecular Pharmacology · 54
The vasoactive intestinal peptide analogue RO25-1553 inhibits the production of TNF and IL-12 by LPS-activated monocytes
1998 · Dominique Dewit, Philippe Gourlet, et al. · Immunology Letters · 47
Different Vasoactive Intestinal Polypeptide Receptor Domains Are Involved in the Selective Recognition of Two VPAC2-Selective Ligands
1999 · Maria G. Juarranz, Jean Van Rampelbergh, et al. · Molecular Pharmacology · 40
Properties of the pituitary adenylate cyclase-activating polypeptide I and II receptors, vasoactive intestinal peptide1, and chimeric amino-terminal pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal peptide1 receptors: evidence for multiple receptor states.
1996 · J Van Rampelbergh, P Gourlet, et al. · Molecular Pharmacology · 40
Pharmacological characterization of the novel helodermin/VIP receptor present in human SUP-T1 lymphoma cell membranes
1989 · Patrick Robberecht, Philippe De Neef, et al. · Regulatory Peptides · 40
The activation of adenylate cyclase by pituitary adenylate cyclase activating polypeptide (PACAP) via helodermin-preferring VIP receptors in human SUP-T1 lymphoblastic membranes
1991 · Philippe Gourlet, Philippe De Neef, et al. · Biochimica et Biophysica Acta (BBA) - Biomembranes · 37
Interaction of lipophilic VIP derivatives with recombinant VIP1/PACAP and VIP2/PACAP receptors
1998 · Philippe Gourlet, Jean Rathé, et al. · European Journal of Pharmacology · 36
Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating peptide (PACAP-27, but not PACAP-38) degradation by the neutral endopeptidase EC 3.4.24.11
1997 · Philippe Gourlet, André Vandermeers, et al. · Biochemical Pharmacology · 36
Interaction of Amino Acid Residues at Positions 8–15 of Secretin with the N‐Terminal Domain of the Secretin Receptor
1996 · Philippe Gourlet, Jean‐Pierre Vilardaga, et al. · European Journal of Biochemistry · 36
PDF
Works count: 60
Citation count: 2,508
H-index: 29
I10-index: 40
Year
Topic
Type